The IMPACT Study

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

C Mikropoulos, CGH Selkirk, S Saya, E Bancroft, E Vertosick, T Dadaev, C Brendler, E Page, A Dias, DG Evans, J Rothwell, L Maehle, K Axcrona, K Richardson, D Eccles, T Jensen, PJ Osther, CJ Van Asperen, H Vasen, LA Kiemeney

2018-01-01

Background:Prostate-specific antigen (PSA) and PSA-velocity (PSAV) have been used to identify men at risk of prostate cancer (PrCa..